21 May 2009
Liver transplantation in two children with severe hepatic graft versus host disease after hematopoietic stem cell transplantation
J Teisseyre, M Teisseyre, P Kaliciński, B Wolska-Kusnierz, M Markiewicz-Kijewska, H Ismail, I Jankowska, M SzymczakAnn Transplant 2009; 14(1): 41-42 :: ID: 880349
Abstract
Backgound: Graft versus host disease (GVHD), a common complication of
hematopoietic stem cell transplantation (HSCT), frequently causes liver injury and in some cases leads to an end stage liver disease. Some authors have suggested that extra hepatic GVHD (skin and intestinal) should be a contraindication to liver transplantation (OLTx) because of a poor survival of these patients. The aim of the study is to present a successful OLTx in two patients with severe chronic GVHD after HSCT.
Material/Method: First case: 8- years-old boy received MUD HSCT due to CD40
ligand deficiency complicated by chronic Cryptosporidium infection with cholangitis sclerosans. GVHD III/IV degree occured 8 days after HSCT. Vanishing bile duct syndrome caused liver failure. Successful OLTx was performed 11 months later after resolution of skin and intestinal symptoms of GVHD. Second case: 6 month old boy with X-linked severe combined immunodeficiency received MUT HSCT. GVHD III degree occured 26 days after HSCT. Six months later, when skin and intestinal symptoms had been resolved, living related OLTx was successfully performed due to an end stage liver involvement.
Results: Both patients have good liver function, full immunological reconstitution and haven't GVHD symptoms respectively six months and four years after OLTx. Conclusions: OLTx appears to be an effective treatment for post HSCT GVHD even when both hepatic and extra hepatic symptoms are present.
Keywords: Liver Transplantation, Stem Cell Transplantation, case report
In Press
Case report
Tongue Carcinoma in Immunosuppressed Patients After Liver and Kidney Transplantation: A Case SeriesAnn Transplant In Press; DOI: 10.12659/AOT.951715
Original article
Prevalence and Risk Factors of Hepatic Steatosis in Kidney Transplant RecipientsAnn Transplant In Press; DOI: 10.12659/AOT.952251
Original article
The Anatomical Landscape of Living Donor Livers: A 101-Case Retrospective Single-Center Study in Indonesia ...Ann Transplant In Press; DOI: 10.12659/AOT.952031
Original article
Decreased Ventilation Duration and ICU Stay Associated With Early Percutaneous Dilatational Tracheostomy Af...Ann Transplant In Press; DOI: 10.12659/AOT.953143
Most Viewed Current Articles
24 Aug 2021 : Review article 20,545
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
29 Dec 2021 : Original article 16,641
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588
05 Apr 2022 : Original article 15,898
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 15,796
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988






